Short Interest in GeoVax Labs Inc. (NASDAQ:GOVX) Increases By 139.4%

GeoVax Labs Inc. (NASDAQ:GOVX) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totaling 150,485 shares, an increase of 139.4% from the June 30th total of 62,850 shares. Based on an average daily trading volume, of 266,107 shares, the days-to-cover ratio is currently 0.6 days. Currently, 4.4% of the shares of the stock are sold short.

Analyst Ratings Changes

Several brokerages recently commented on GOVX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GeoVax Labs in a research note on Friday, July 17th. D. Boral Capital reissued a “hold” rating on shares of GeoVax Labs in a report on Thursday, April 16th. Finally, Wall Street Zen raised shares of GeoVax Labs from a “sell” rating to a “hold” rating in a report on Sunday, June 21st. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $150.00.

GeoVax Labs Stock Performance

NASDAQ:GOVX opened at $0.72 on Tuesday. GeoVax Labs has a fifty-two week low of $0.69 and a fifty-two week high of $20.62. The firm has a market cap of $2.49 million, a PE ratio of -0.04 and a beta of 3.68. The business has a 50 day moving average price of $1.52 and a 200-day moving average price of $1.83.

GeoVax Labs (NASDAQ:GOVX) last released its quarterly earnings results on Monday, July 27th. The company reported ($0.97) EPS for the quarter, beating analysts’ consensus estimates of ($2.16) by $1.19. Research analysts predict that GeoVax Labs will post -8.69 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of GOVX. Jane Street Group LLC bought a new position in shares of GeoVax Labs during the first quarter valued at approximately $27,000. Armistice Capital LLC bought a new stake in shares of GeoVax Labs in the 3rd quarter worth approximately $253,000. Renaissance Technologies LLC purchased a new stake in shares of GeoVax Labs in the 4th quarter worth approximately $104,000. Finally, HRT Financial LP bought a new position in GeoVax Labs during the 4th quarter valued at approximately $31,000. 6.09% of the stock is currently owned by institutional investors.

GeoVax Labs Company Profile

GeoVax Labs, Inc is a clinical-stage biotechnology company focused on the development of novel vaccines and immunotherapies against infectious diseases. Leveraging a proprietary Modified Vaccinia Ankara (MVA) viral vector platform, GeoVax aims to induce robust and durable immune responses by expressing virus-like particles (VLPs) in vaccinated individuals. The company’s pipeline encompasses vaccine candidates for HIV, Ebola, Lassa, Zika, MERS and emerging coronaviruses, reflecting a commitment to addressing high-priority global public health threats.

The cornerstone of GeoVax’s technology is its MVA-VLP platform, which combines the safety profile of a non-replicating poxvirus vector with the potent antigen presentation of VLPs.